Year |
Citation |
Score |
2020 |
Saljic A, Soattin L, Trachsel DS, Boddum K, Jespersen T. In vivo knockdown of SK3 channels using antisense oligonucleotides protects against atrial fibrillation in rats. Journal of Molecular and Cellular Cardiology. 147: 18-26. PMID 32768409 DOI: 10.1016/J.Yjmcc.2020.07.011 |
0.377 |
|
2019 |
Saljic A, Muthukumarasamy KM, la Cour JM, Boddum K, Grunnet M, Berchtold MW, Jespersen T. Impact of arrhythmogenic calmodulin variants on small conductance Ca -activated K (SK3) channels. Physiological Reports. 7: e14210. PMID 31587513 DOI: 10.14814/Phy2.14210 |
0.393 |
|
2018 |
Dreisig K, Sund L, Dommer MW, Kristensen NP, Boddum K, Viste R, Fredholm S, Odum N, Jäättelä M, Skov S, Kornum BR. Human P2Y Expression Level Affects Human P2X7 Receptor-Mediated Cell Death. Frontiers in Immunology. 9: 1159. PMID 29937766 DOI: 10.3389/Fimmu.2018.01159 |
0.382 |
|
2018 |
Skibsbye L, Bengaard AK, Uldum-Nielsen AM, Boddum K, Christ T, Jespersen T. Inhibition of Small Conductance Calcium-Activated Potassium (SK) Channels Prevents Arrhythmias in Rat Atria During β-Adrenergic and Muscarinic Receptor Activation. Frontiers in Physiology. 9: 510. PMID 29922167 DOI: 10.3389/Fphys.2018.00510 |
0.326 |
|
2018 |
Munch AS, Saljic A, Boddum K, Grunnet M, Hougaard C, Jespersen T. Pharmacological rescue of mutated K3.1 ion-channel linked to progressive myoclonus epilepsies. European Journal of Pharmacology. PMID 29894724 DOI: 10.1016/J.Ejphar.2018.06.015 |
0.377 |
|
2018 |
Boddum K, Saljic A, Jespersen T, Christensen AH. A Novel SCN5A Variant Associated with Abnormal Repolarization, Atrial Fibrillation, and Reversible Cardiomyopathy. Cardiology. 140: 8-13. PMID 29635243 DOI: 10.1159/000487475 |
0.332 |
|
2017 |
Simonsen C, Boddum K, von Schoubye NL, Kloppenburg A, Sønderskov K, Hansen SL, Kristiansen U. Anticonvulsive evaluation of THIP in the murine pentylenetetrazole kindling model: lack of anticonvulsive effect of THIP despite functional δ-subunit-containing GABAA receptors in dentate gyrus granule cells. Pharmacology Research & Perspectives. 5. PMID 28805971 DOI: 10.1002/Prp2.322 |
0.493 |
|
2017 |
Boddum K, Hougaard C, Xiao-Ying Lin J, von Schoubye NL, Jensen HS, Grunnet M, Jespersen T. Kv3.1/Kv3.2 channel positive modulators enable faster activating kinetics and increase firing frequency in fast-spiking GABAergic interneurons. Neuropharmacology. 118: 102-112. PMID 28242439 DOI: 10.1016/j.neuropharm.2017.02.024 |
0.564 |
|
2016 |
Boddum K, Jensen TP, Magloire V, Kristiansen U, Rusakov DA, Pavlov I, Walker MC. Astrocytic GABA transporter activity modulates excitatory neurotransmission. Nature Communications. 7: 13572. PMID 27886179 DOI: 10.1038/Ncomms13572 |
0.635 |
|
2015 |
Chang P, Augustin K, Boddum K, Williams S, Sun M, Terschak JA, Hardege JD, Chen PE, Walker MC, Williams RS. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain : a Journal of Neurology. PMID 26608744 DOI: 10.1093/Brain/Awv325 |
0.453 |
|
2014 |
Boddum K, Frølund B, Kristiansen U. The GABAA antagonist DPP-4-PIOL selectively antagonises tonic over phasic GABAergic currents in dentate gyrus granule cells. Neurochemical Research. 39: 2078-84. PMID 25103229 DOI: 10.1007/S11064-014-1397-9 |
0.68 |
|
2012 |
Vardya I, Hoestgaard-Jensen K, Nieto-Gonzalez JL, Dósa Z, Boddum K, Holm MM, Wolinsky TD, Jones KA, Dalby NO, Ebert B, Jensen K. Positive modulation of δ-subunit containing GABA(A) receptors in mouse neurons. Neuropharmacology. 63: 469-79. PMID 22579928 DOI: 10.1016/j.neuropharm.2012.04.023 |
0.469 |
|
Show low-probability matches. |